Revlimid (lenalidomide) is a brand-name oral capsule that’s prescribed for certain types of myeloma, lymphoma, and anemia. As with other drugs, Revlimid can cause side effects, such as skin rash and ...

Right now, CELMoDs are being studied in patients whose cancer has returned after prior treatment, but their role could expand ...

Stage 1 multiple myeloma features low beta-2 microglobulin, high albumin, and no organ damage, often detected incidentally. Diagnosis involves blood, urine, imaging tests, and bone marrow biopsy to ...

The US Food and Drug Administration (FDA) announced today that it has halted a clinical trial of the anti-cancer drug Revlimid (lenalidomide) due to safety concerns. The drug, manufactured by Celgene, ...

Revlimid (lenalidomide) is a prescription drug that works to treat multiple myeloma and other conditions by interfering with cancer cells. Your response to this drug may vary based on your medical ...

FDA approved Amneal's generic lenalidomide capsules, referencing Celgene's Revlimid, for manufacturing and sale starting in 2026. Amneal launched mesalamine 800 mg delayed-release tablets for ...

Sustained MRD negativity in patients with newly diagnosed multiple myeloma treated with carfilzomib-lenalidomide-dexamethasone with or without isatuximab (phase III IsKia trial). This is an ASCO ...

Lupin Ltd. received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Lenalidomide Capsules within the range of 2.5 mg to 25 mg, the ...